Defining the central role of NF-κB in these pathways may offer new therapeutic targets for breast cancer treatment (Ahmed et al. 2006); however, it also increased the challenge of implementation since NF-κB is currently involved in the regulation of more than 150 target genes (Pahl 1999). This evidence concerns the gene NFKB1 and breast cancer.